Similar articles

• Prescription for an ailing pharmaceutical industry.

  Demain AL. Demain AL. Nat Biotechnol. 2002 Apr;20(4):331. doi: 10.1038/nbt0402-331. Nat Biotechnol. 2002. PMID: 11923826 No abstract available.
• Rediscovering plant-based drugs.

  Littleton J, Falcone D, Davies HM. Littleton J, et al. Nat Biotechnol. 2003 Aug;21(8):843-4. doi: 10.1038/nbt0803-843b. Nat Biotechnol. 2003. PMID: 12894188 No abstract available.
• Michigan's next wave of biopharmaceutical entrepreneurship.

  Kerppola R, van de Walle M, Surine S. Kerppola R, et al. Nat Biotechnol. 2003 Sep;21(9):1109-11. doi: 10.1038/nbt0903-1109. Nat Biotechnol. 2003. PMID: 12949575 No abstract available.
• A better prescription for drug-development financing.

  Kessel M, Frank F. Kessel M, et al. Nat Biotechnol. 2007 Aug;25(8):859-66. doi: 10.1038/nbt0807-859. Nat Biotechnol. 2007. PMID: 17687358 Review. No abstract available.
• A change in the market--investing in diagnostics.

  Batchelder K, Miller P. Batchelder K, et al. Nat Biotechnol. 2006 Aug;24(8):922-6. doi: 10.1038/nbt0806-922. Nat Biotechnol. 2006. PMID: 16900131 Review. No abstract available.